In the News Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs Partner with Us For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Events In the News Presentations & Publications Stock Information Corporate Governance Financials Investor Resources CMO Chief Medical Officer 360° Newsletter August 2020 Source CMO360° August 1, 2020 Bacteria as Living Microrobots to Fight Cancer Source The Scientist Magazine April 1, 2020 Turning Synthetic Biology Into 'Living Drugs': Synlogics Aoife Brennan on The Long Run Source Timmerman Report October 15, 2019 How phenylketonuria, a once-neglected disease, became a proving ground for new drugs Source Chemical & Engineering News (C&EN) July 8, 2019 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Email Alerts Contact IR RSS Feeds Print Page Email Page
CMO Chief Medical Officer 360° Newsletter August 2020 Source CMO360° August 1, 2020 Bacteria as Living Microrobots to Fight Cancer Source The Scientist Magazine April 1, 2020 Turning Synthetic Biology Into 'Living Drugs': Synlogics Aoife Brennan on The Long Run Source Timmerman Report October 15, 2019 How phenylketonuria, a once-neglected disease, became a proving ground for new drugs Source Chemical & Engineering News (C&EN) July 8, 2019 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
Turning Synthetic Biology Into 'Living Drugs': Synlogics Aoife Brennan on The Long Run Source Timmerman Report October 15, 2019
How phenylketonuria, a once-neglected disease, became a proving ground for new drugs Source Chemical & Engineering News (C&EN) July 8, 2019